Effect ot Fenugreek in treatment of Acne Vulgaris

Early Phase 1

• Conditions: Acne vulgaris.; Acne vulgaris

• Registration Number: IRCT2015091123978N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

age 12 to 30 years; GAGS score between 1 and 30; signature consent form.
Exclusion criteria: previous consumption of oral acne controller medications, such as antibiotics, isotretinoin, oral contraceptive pills; administration of drugs that caused acne such as testosterone, progesterone, steroids, lithium, phenytoin, and isoniazid; patients with symptoms of endocrine disorders especially hyperandrogegism, including polycystic ovarian syndrome (oligomenorrhea, polycystic ovaries, hirsutism), Cushing syndrome (rapid weight gain, buffalo hump, moon face, excess sweating, purple or red striae on the body and hirsutism), CAH, androgen-secreting tumors, and acromegaly; severe skin problem; women who were pregnant or lactating.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of skin lesions. Timepoint: At baseline, 30 and 60 days after intervention. Method of measurement: Global Acne Grading System (GAGS).

Secondary Outcome Measures

Name	Time	Method
Changes in lesions count (total, inflammatory, non-inflammatory and regional). Timepoint: At baseline, 30 and 60 days after intervention. Method of measurement: visual counting.